UBS Group AG (UBS) Stock Price & Analysis
UBS Group AG (UBS) closed at USD 46.87 on Thursday, October 22, 2026, down 2.21% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 47.93; the Oct 22, 2026 session ranged USD 46.63–47.56 on volume of 2,090,121 shares. Market capitalization is $143.50B, with a 52-week range of USD 36.3–55.99 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/UBS.md
Key facts (UBS)
- 4 of 80 tracked superinvestors hold UBS (13F, Q2 2026): 1 new, 0 added, 3 reduced, 0 unchanged.
- Analysts: Hold (mean 2.67 on a 1–5 scale) (3 analysts), mean target USD 55.03 (range 50–62.6).
- Total return with dividends: 1Y +25.8% vs S&P 500 +14.9%; 5Y +204.2% vs S&P 500 +80.3%.
- Next earnings: 2026-10-28, EPS estimate USD 0.96, revenue estimate $10.9B.
Superinvestors (SEC 13F-HR, Q2 2026) (UBS)
4 of 80 tracked investors hold UBS. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Richard Pzena | Pzena Investment Management | 2.66% | $906M | Reduced -14.8% |
| Samantha McLemore | Patient Capital Management | 1.57% | $47.3M | Reduced -23.2% |
| Dodge & Cox Funds | Dodge & Cox | 0.87% | $1.67B | Reduced -0.0% |
| Viking Global | Viking Global Investors | 0.34% | $121M | New position |
Analysts (UBS)
Consensus Hold (mean 2.67 on a 1–5 scale), 3 analysts; mean target USD 55.03 (low 50, high 62.6).
Total return (dividends reinvested) (UBS)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +25.8% | +204.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +25.9% | +24.9% |
| Volatility (annualized) | 26.7% | 31.1% |
| Max drawdown | -26.1% (Jan 2026→Mar 2026) | -29.6% (Feb 2022→Oct 2022) |
UBS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.96 | $0.00 | — | $10.90B | 1 |
| Next quarter (ends Dec 2026) | $0.99 | $0.00 | — | $10.78B | 1 |
| Current fiscal year (ends Dec 2026) | $3.41 | $3.34 | +2.0% | $43.92B | 2 |
| Next fiscal year (ends Dec 2027) | $4.08 | $4.14 | -1.5% | $45.21B | 3 |
UBS options: expected move
Options price a move of about ±8.3% (±$3.90) by Nov 20, 2026, which includes earnings on Oct 28, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 36.5% | ±8.3% |
| Dec 18, 2026 | 56 | 31.0% | ±9.9% |
| Jan 15, 2027 | 84 | 29.2% | ±11.1% |
| Feb 19, 2027 | 119 | 29.8% | ±13.8% |
| May 21, 2027 | 210 | 30.3% | ±18.5% |
30-day implied volatility 32.1% vs 26.6% realized over the last 30 trading days. Put/call ratio (volume) 2.05. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 46.87 |
|---|---|
| Change | ▼ 2.21% (down) |
| Previous Close | USD 47.93 |
| Open | USD 47.02 |
| Day Range | USD 46.63 – 47.56 |
| 52-Week Range | USD 36.3 – 55.99 |
| Volume | 2,090,121 shares |
| Market Cap | $143.50B |
| Exchange | NYQ |
Technical Analysis (UBS)
Nexqual's technical model rates UBS "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.37 (neutral) |
| vs SMA50 | Below (USD 50.98) |
| MACD | -0.98 (negative) |
Analyst Ratings (UBS)
Wall Street analysts rate UBS "Hold" based on 3 analysts, with a mean price target of USD 55.03 (range USD 50–62.6), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 55.03 |
| High Target | USD 62.6 |
| Low Target | USD 50 |
| Buy / Hold / Sell | 1 / 2 / 0 |
Earnings (UBS)
| Next Earnings Date | 2026-10-28 |
|---|---|
| EPS Estimate | USD 0.96 |
| Revenue Estimate | $10.90B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.93 vs est 0.98 ▼ miss |
| 2026-03-31 | USD 0.95 vs est 0.83 ▲ beat |
| 2025-12-31 | USD 0.67 vs est 0.67 ▼ miss |
| 2025-09-30 | USD 0.92 vs est 0.6 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (UBS)
| Total Revenue | $53.04B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +14.60% |
| Gross Margin | +0.00% |
| Operating Margin | +31.00% |
| Profit Margin | +17.95% |
| ROE | +10.67% |
| Total Cash | $575.37B |
| Total Debt | $599.21B |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (UBS)
Nexqual rates UBS Group AG's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Critical — Revenue -13% YoY (annual), sharp decline |
|---|---|
| Profitability | Solid — Net margin 16% (last 12 months); banks have no gross margin |
| Balance Sheet | N/A — Not comparable for banks: deposits and customer funds sit on the balance sheet, so cash vs debt does not measure safety (SEC industry: National Commercial Banks) |
| Cash Flow | N/A — Not meaningful for banks and lenders: lending and trading move operating cash flow by billions each year (SEC industry: National Commercial Banks) |
| Efficiency | Mixed — ROE 11%, ROA 0.6% |
Ownership (UBS)
| Insider Ownership | +0.06% |
|---|---|
| Institutional Ownership | +51.23% |
| Shares Outstanding | 3.06B |
| Float | 3.05B |
| Short % of Float | +0.19% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (UBS)
UBS Group AG is led by Sergio P. Ermotti, Group CEO & President of the Group Executive Board, per Nexqual as of October 23, 2026 at 09:26 UTC.
| Group CEO & President of the Group Executive Board | Sergio P. Ermotti |
|---|---|
| Group CFO & Member of Executive Board | Todd Tuckner |
| Co-President Investment Bank & Member of Executive Board | George Athanasopoulos |
| President UBS Switzerland, President of Personal & Corporate Banking and Member of the GEB | Sabine Keller-Busse |
| President of UBS Americas, Co-President Global Wealth Management & Member of GEB | Robert Karofsky |
Major Backers & Investors (UBS)
Notable institutional backers of UBS Group AG include UBS Group AG, NORGES BANK, Fisher Asset Management, LLC, according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| UBS Group AG | 3.09% |
| NORGES BANK | 2.77% |
| Fisher Asset Management, LLC | 1.88% |
| Massachusetts Financial Services Co. | 1.82% |
| Wellington Management | 1.72% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 1.6% |
| FMR, LLC | 1.6% |
| Cevian Capital II Gp Ltd | 1.39% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.83% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBVA | Banco Bilbao Vizcaya Argentaria | USD 25.03 | ▼ 2.95% |
| SMFG | Sumitomo Mitsui Financial Group | USD 24.09 | ▼ 1.75% |
| BMO | Bank Of Montreal | USD 170.44 | ▼ 0.01% |
| BNS | Bank Nova Scotia Halifax Pfd 3 | USD 93.41 | ▼ 0.63% |
| SAN | Banco Santander, S.A. Sponsored | USD 12.9 | ▼ 2.93% |
| TD | Toronto Dominion Bank (The) | USD 125.12 | ▲ 0.34% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt